[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-110-2-medical-surgical-039":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-110-2-內外科護理學-039","nurse-110-2-medical-surgical-039",110,2,39,"有關化學治療特性的敘述，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"使用具細胞毒性藥物來縮小腫瘤或控制症狀","化學治療藥物大多可以通過血腦屏障","使用多種不同抗癌藥物來增加療效，但副作用也會增加","目前治療方式多採高劑量、較無毒性，減少次數、增加休息時間方式進行","A",null,[],"本題考點在於化學治療的基本特性。化學治療是利用具細胞毒性的藥物干擾癌細胞分裂增殖，以縮小腫瘤、控制症狀或清除微轉移，故A正確。多數化療藥物分子特性使其「不易」通過血腦屏障，這也是中樞神經常成為藥物庇護所的原因，故B「大多可通過血腦屏障」錯。合併多種藥物的目的是利用不同機轉、減少抗藥性並在「不重疊毒性」下增效，並非單純增加副作用，B、C的敘述取向不符設計原意，故C錯。D「高劑量、較無毒性、減少次數」自相矛盾且不符實務，錯。故正確為A。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840765978]